"ID","biorxiv","published","title","year","journal","doi","author","author_name","author_email","author_address","hypothesis","rationale","MR_design","outcome","outcome_info","outcome_group","outcome_definition","outcome_study","outcome_age_range","outcome_sex","outcome_n_case_current","outcome_n_control_current","outcome_n_case_og","outcome_n_control_og","outcome_n_difference_reason","outcome_health_status","outcome_population","exposure","exposure_definition","exposure_study","exposure_age","exposure_sex","exposure_n_current","exposure_n_og","exposure_n_difference_reason","exposure_health_status","exposure_population","exposure_covariates_model","exposure_genotyping_dataset","exposure_independence","exposure_pleiotropy","exposure_pvalue","exposure_palindrome","exposure_proxy","exposure_HWE","IV_single","IV_multiple","IV_GRS","n_SNP_og","n_SNP_difference_reason","power_calculation","power_calculation_how","MR_method","MR_sensitivity_method1","MR_sensitivity_method2","MR_sensitivity_method3","MR_sensitivity_method4","MR_sensitivity_method5","MR_sensitivity_method_results","IV_strength","analysis_software","analysis_programme","replication_independent","replication_subsetting","multiple_testing","exposure_units","outcome_units","effect_estimate","estimate","se","ci_percent","ci_lower","ci_upper","p","adjustment_method","p_adjusted","limitations_overall","limitations_pleiotropy","limitations_population_stratification","limitations_statistical_power","notes","ID_analysis"
11,"no","yes","High body mass index and cancer risk—a Mendelian randomisation study",2016,"European Journal of Epidemiology","10.1007/s10654-016-0147-5","Benn","Marianne Benn","marianne.benn@regionh.dk","Department of Clinical Biochemistry, Gentofte Hospital, Copenhagen University Hospital, Kildega ̊rdsvej 28, 2900 Gentofte, Denmark","Effect of body mass index on cancer","High body mass index (BMI) has been associ- ated with increased risk of some cancer. Whether these reflect causal associations is unknown. We examined this issue.","One-sample","breast cancer","premenopausal","cancer","breast cancer (ICD-7:174; ICD-10:C50)","Current study","20+","female","507","20482",NA,NA,NA,"Healthy","European","BMI","BMI","Current study","20+","female","20989","Manually fill",NA,"Healthy","European ancestry",NA,"Not discussed","Not discussed","Confounder analysis","Not discussed","Not discussed","Not discussed","Not discussed",NA,NA,"5",NA,NA,"yes","Power to exclude a causal risk of cancer (odds ratio) at a two-sided a of 0.05 and b of 80 % was calculated using an online power calculation tool (https://sb452.shi nyapps.io/power/) for instrumental variable analysis in Mendelian Randomization studies with binary outcomes","Two-stage-least-squares",NA,NA,NA,NA,NA,"None performed","F statistic > 10","STATA","ivreg2 and ivpois","Not discussed","Not discussed","Not discussed","10 kg/m2","case/control","Hazard ratio","0.47",NA,"95","0.14000000000000001","1.51","0.2",NA,NA,NA,"To minimize influence from pleiotropy, we carefully selected genetic instruments and used genetic variants located in five different genes combined in an allele score for body mass index, making it unlikely that the genetic variants in the allele score have the same pleiotropic effects","Not discussed","Lack of power for rare cancer",NA,64
58,"no","yes","Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent",2016,"PLOS Medicine","10.1371/journal.pmed.1002105","Guo","Wei Zheng","wei.zheng@vanderbilt.edu","Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America","Effect of BMI on breast cancer","Observational epidemiological studies have shown that high body mass index (BMI) is associated with a reduced risk of breast cancer in premenopausal women but an increased risk in postmenopausal women. It is unclear whether this association is mediated through shared genetic or environmental factors.","One-sample","breast cancer","premenopausal","cancer","Defined in Breast Cancer Association Consortium (BCAC)","Current study",NA,"female","19262",NA,"19262",NA,"Results table quotes total N not split by case/control","Case/control","European","BMI","BMI > 25.5-25.9 versus BMI < 25.5","Locke 2015 BMI European adults both",NA,"female","19262","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European","Not discussed","HapMap Project phase 3 data","Selected independent SNPs, defined as r2 < 0.1","Not discussed","5x10-8","Not discussed","Not discussed","Not discussed",NA,NA,"84","77","SNPs from Locke et al (77) were combined with SNPs associated with variation in BMI identified from the NHGRI-EBI Catalog of Published Genome-Wide Association Studies in August 2015","Not discussed",NA,"Logistic regression model","MR Egger",NA,NA,NA,NA,"In addition to pooled analysis also conducted meta-analysis, we estimated the risk of breast cancer associated with BMI-GS in each of the BCAC studies","r2 (1.27%)","R (v 3.02)","Not discussed","No","Used summary statistics from the Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) Project to look at BMI and breast cancer risk","No","kg/m2","case/control","OR","0.96",NA,"95","0.88","1.05",NA,NA,NA,"Our study has certain limitations. To date, GWAS-identified SNPs represent a small, but statistically significant, portion of the explained variance of observed BMI—approximately 2.7%","some of the BMI-associated SNPs may be related to other traits. However, we were unable to evaluate these hypotheses in our study.","Not discussed","Using data from approximately 146,000 women involved in two large consortia, we provide strong evidence of an inverse association between genetically predicted BMI and breast cancer risk for both premenopausal and postmenopausal women",NA,1047
58,"no","yes","Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent",2016,"PLOS Medicine","10.1371/journal.pmed.1002105","Guo","Wei Zheng","wei.zheng@vanderbilt.edu","Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America","Effect of BMI on breast cancer","Observational epidemiological studies have shown that high body mass index (BMI) is associated with a reduced risk of breast cancer in premenopausal women but an increased risk in postmenopausal women. It is unclear whether this association is mediated through shared genetic or environmental factors.","One-sample","breast cancer","premenopausal","cancer","Defined in Breast Cancer Association Consortium (BCAC)","Current study",NA,"female","19262",NA,"19262",NA,"Results table quotes total N not split by case/control","Case/control","European","BMI","BMI > 26-26.5 versus BMI < 25.5","Locke 2015 BMI European adults both",NA,"female","19262","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European","Not discussed","HapMap Project phase 3 data","Selected independent SNPs, defined as r2 < 0.1","Not discussed","5x10-8","Not discussed","Not discussed","Not discussed",NA,NA,"84","77","SNPs from Locke et al (77) were combined with SNPs associated with variation in BMI identified from the NHGRI-EBI Catalog of Published Genome-Wide Association Studies in August 2015","Not discussed",NA,"Logistic regression model","MR Egger",NA,NA,NA,NA,"In addition to pooled analysis also conducted meta-analysis, we estimated the risk of breast cancer associated with BMI-GS in each of the BCAC studies","r2 (1.27%)","R (v 3.02)","Not discussed","No","Used summary statistics from the Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) Project to look at BMI and breast cancer risk","No","kg/m2","case/control","OR","0.91",NA,"95","0.83","1",NA,NA,NA,"Our study has certain limitations. To date, GWAS-identified SNPs represent a small, but statistically significant, portion of the explained variance of observed BMI—approximately 2.7%","some of the BMI-associated SNPs may be related to other traits. However, we were unable to evaluate these hypotheses in our study.","Not discussed","Using data from approximately 146,000 women involved in two large consortia, we provide strong evidence of an inverse association between genetically predicted BMI and breast cancer risk for both premenopausal and postmenopausal women",NA,1058
58,"no","yes","Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent",2016,"PLOS Medicine","10.1371/journal.pmed.1002105","Guo","Wei Zheng","wei.zheng@vanderbilt.edu","Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America","Effect of BMI on breast cancer","Observational epidemiological studies have shown that high body mass index (BMI) is associated with a reduced risk of breast cancer in premenopausal women but an increased risk in postmenopausal women. It is unclear whether this association is mediated through shared genetic or environmental factors.","One-sample","breast cancer","premenopausal","cancer","Defined in Breast Cancer Association Consortium (BCAC)","Current study",NA,"female","19262",NA,"19262",NA,"Results table quotes total N not split by case/control","Case/control","European","BMI","BMI > 26.5 versus BMI < 25.5","Locke 2015 BMI European adults both",NA,"female","19262","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European","Not discussed","HapMap Project phase 3 data","Selected independent SNPs, defined as r2 < 0.1","Not discussed","5x10-8","Not discussed","Not discussed","Not discussed",NA,NA,"84","77","SNPs from Locke et al (77) were combined with SNPs associated with variation in BMI identified from the NHGRI-EBI Catalog of Published Genome-Wide Association Studies in August 2015","Not discussed",NA,"Logistic regression model","MR Egger",NA,NA,NA,NA,"In addition to pooled analysis also conducted meta-analysis, we estimated the risk of breast cancer associated with BMI-GS in each of the BCAC studies","r2 (1.27%)","R (v 3.02)","Not discussed","No","Used summary statistics from the Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) Project to look at BMI and breast cancer risk","No","kg/m2","case/control","OR","0.78",NA,"95","0.67","0.9",NA,NA,NA,"Our study has certain limitations. To date, GWAS-identified SNPs represent a small, but statistically significant, portion of the explained variance of observed BMI—approximately 2.7%","some of the BMI-associated SNPs may be related to other traits. However, we were unable to evaluate these hypotheses in our study.","Not discussed","Using data from approximately 146,000 women involved in two large consortia, we provide strong evidence of an inverse association between genetically predicted BMI and breast cancer risk for both premenopausal and postmenopausal women",NA,1069
58,"no","yes","Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent",2016,"PLOS Medicine","10.1371/journal.pmed.1002105","Guo","Wei Zheng","wei.zheng@vanderbilt.edu","Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America","Effect of BMI on breast cancer","Observational epidemiological studies have shown that high body mass index (BMI) is associated with a reduced risk of breast cancer in premenopausal women but an increased risk in postmenopausal women. It is unclear whether this association is mediated through shared genetic or environmental factors.","One-sample","breast cancer","premenopausal","cancer","Defined in Breast Cancer Association Consortium (BCAC)","Current study",NA,"female","19262",NA,"19262",NA,"Results table quotes total N not split by case/control","Case/control","European","BMI","5kg/m2 increase in BMI","Locke 2015 BMI European adults both",NA,"female","19262","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European","Not discussed","HapMap Project phase 3 data","Selected independent SNPs, defined as r2 < 0.1","Not discussed","5x10-8","Not discussed","Not discussed","Not discussed",NA,NA,"84","77","SNPs from Locke et al (77) were combined with SNPs associated with variation in BMI identified from the NHGRI-EBI Catalog of Published Genome-Wide Association Studies in August 2015","Not discussed",NA,"Logistic regression model","MR Egger",NA,NA,NA,NA,"In addition to pooled analysis also conducted meta-analysis, we estimated the risk of breast cancer associated with BMI-GS in each of the BCAC studies","r2 (1.27%)","R (v 3.02)","Not discussed","No","Used summary statistics from the Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) Project to look at BMI and breast cancer risk","No","kg/m2","case/control","OR","0.44",NA,"95","0.31","0.62","9.91 × 10−8",NA,NA,"Our study has certain limitations. To date, GWAS-identified SNPs represent a small, but statistically significant, portion of the explained variance of observed BMI—approximately 2.7%","some of the BMI-associated SNPs may be related to other traits. However, we were unable to evaluate these hypotheses in our study.","Not discussed","Using data from approximately 146,000 women involved in two large consortia, we provide strong evidence of an inverse association between genetically predicted BMI and breast cancer risk for both premenopausal and postmenopausal women",NA,1080
